Cargando…
Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage
This cross-sectional study examines the use of telemedicine for buprenorphine inductions among individuals with commercial insurance or Medicare Advantage during the temporary repeal of the Ryan Haight Act requirement of in-person evaluation before prescribing buprenorphine during to the COVID-19 pa...
Autores principales: | Barsky, Benjamin A., Busch, Alisa B., Patel, Sadiq Y., Mehrotra, Ateev, Huskamp, Haiden A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739765/ https://www.ncbi.nlm.nih.gov/pubmed/34989798 http://dx.doi.org/10.1001/jamanetworkopen.2021.42531 |
Ejemplares similares
-
Patient and Clinician Characteristics Associated with Use of Telemedicine for Buprenorphine Induction Among Medicare Beneficiaries
por: Patel, Sadiq Y., et al.
Publicado: (2022) -
Trends in Outpatient Telemedicine Utilization Among Rural Medicare Beneficiaries, 2010 to 2019
por: Barnett, Michael L., et al.
Publicado: (2021) -
Association Between Telemedicine Use in Nonmetropolitan Counties and Quality of Care Received by Medicare Beneficiaries With Serious Mental Illness
por: Wang, Bill, et al.
Publicado: (2022) -
Disruptions in Care for Medicare Beneficiaries With Severe Mental Illness During the COVID-19 Pandemic
por: Busch, Alisa B., et al.
Publicado: (2022) -
Adoption of telemedicine services by substance abuse treatment facilities in the U.S.
por: Uscher-Pines, Lori, et al.
Publicado: (2020)